BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 22750942)

  • 1. [Kidney and bone update : the 5-year history and future of CKD-MBD. Treatment for dialysis-related amyloidosis update].
    Yamamoto S; Kazama JJ; Narita I
    Clin Calcium; 2012 Jul; 22(7):1089-98. PubMed ID: 22750942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent progress in understanding dialysis-related amyloidosis.
    Yamamoto S; Kazama JJ; Narita I; Naiki H; Gejyo F
    Bone; 2009 Jul; 45 Suppl 1():S39-42. PubMed ID: 19303954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Historical background and clinical treatment of dialysis-related amyloidosis.
    Yamamoto S; Gejyo F
    Biochim Biophys Acta; 2005 Nov; 1753(1):4-10. PubMed ID: 16226497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current clinical aspects of dialysis-related amyloidosis in chronic dialysis patients.
    Saito A; Gejyo F
    Ther Apher Dial; 2006 Aug; 10(4):316-20. PubMed ID: 16911183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of advanced dialysis technology on the prevalence of dialysis-related amyloidosis in long-term maintenance dialysis patients.
    Schiffl H
    Hemodial Int; 2014 Jan; 18(1):136-41. PubMed ID: 23718290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beta2-microglobulin and renal bone disease.
    Wada T; Miyata T; Sakai H; Kurokawa K
    Perit Dial Int; 1999; 19 Suppl 2():S413-6. PubMed ID: 10406556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Usefulness of magnetic resonance imaging of the wrist for the early diagnosis of dialysis-related amyloidosis].
    Mochizuki T; Mitobe M; Mifune N; Takahashi M
    Nihon Jinzo Gakkai Shi; 1999 Jan; 41(1):14-20. PubMed ID: 10077983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dialysis-related amyloidosis: late finding or hidden epidemic?
    Dember LM; Jaber BL
    Semin Dial; 2006; 19(2):105-9. PubMed ID: 16551286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis, pathogenesis, and treatment of dialysis-related amyloidosis.
    Miyata T; Inagi R; Kurokawa K
    Miner Electrolyte Metab; 1999; 25(1-2):114-7. PubMed ID: 10207272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nontransplant therapy for dialysis-related amyloidosis.
    Copley JB; Lindberg JS
    Semin Dial; 2001; 14(2):94-8. PubMed ID: 11264774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Diagnostic and therapeutic aspects of dialysis-related amyloidosis].
    Kopeć J
    Przegl Lek; 2006; 63(7):567-72. PubMed ID: 17203811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Mechanism of beta(2)-microglobulin-related amyloid fibril formation in CKD].
    Yamamoto S; Kazama JJ
    Clin Calcium; 2007 May; 17(5):740-4. PubMed ID: 17471004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathogenesis and management of dialysis-related amyloid bone disease.
    Nangaku M; Miyata T; Kurokawa K
    Am J Med Sci; 1999 Jun; 317(6):410-5. PubMed ID: 10372842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dialysis related amyloidosis: a disease of chronic retention and inflammation?
    Floege J; Schäffer J; Koch KM; Shaldon S
    Kidney Int Suppl; 1992 Oct; 38():S78-85. PubMed ID: 1405384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal transplantation relieves the symptoms but does not reverse beta 2-microglobulin amyloidosis.
    Mourad G; Argilés A
    J Am Soc Nephrol; 1996 May; 7(5):798-804. PubMed ID: 8738817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term complications of dialysis: pathogenic factors with special reference to amyloidosis.
    Gejyo F; Homma N; Arakawa M
    Kidney Int Suppl; 1993 Jun; 41():S78-82. PubMed ID: 8320951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Diagnosis and treatment of dialysis-related amyloidosis: focusing on carpal tunnel syndrome].
    Nishi S
    Brain Nerve; 2014 Jul; 66(7):783-93. PubMed ID: 24998823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term efficacy and safety of the small-sized β2-microglobulin adsorption column for dialysis-related amyloidosis.
    Yamamoto Y; Hirawa N; Yamaguchi S; Ogawa N; Takeda H; Shibuya K; Kawahara K; Kojima H; Dobashi Y; Fujita M; Azusima K; Miyazaki N; Kobayashi M; Kobayashi C; Fujiwara A; Yuto J; Saka S; Yatsu K; Toya Y; Yasuda G; Ohnishi T; Umemura S
    Ther Apher Dial; 2011 Oct; 15(5):466-74. PubMed ID: 21974700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiological survey and risk factor analysis of dialysis-related amyloidosis including destructive spondyloarthropathy, dialysis amyloid arthropathy, and carpal tunnel syndrome.
    Tagami A; Tomita M; Adachi S; Tsuda K; Yamada S; Chiba K; Okazaki N; Yonekura A; Tsujimoto R; Kajiyama S; Matsubayashi S; Miyamoto T; Mochizuki Y; Ohba K; Osaki M
    J Bone Miner Metab; 2020 Jan; 38(1):78-85. PubMed ID: 31414282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Beta 2-microglobulin and dialysis-related amyloidosis].
    Gejyo F
    Rinsho Byori; 2001 Mar; 49(3):244-8. PubMed ID: 11307323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.